Archive
Every story, newest first.
Friday, October 30, 2026
Politics
President Volodymyr Zelenskyy welcomed US approval of the $2.1 billion sale of 500 Patriot PAC-3 missiles to Ukraine but said deliveries from new production may begin only in a few years, and he asked partners to release interceptors from their own stocks for this winter.
Infrastructure
TOTE Services has selected Hanwha Defense USA to build a Medium Landing Ship at Hanwha Philly Shipyard under a $269 million contract, with options for three more ships and construction due to start in late 2027.
Technology
CISA added two Ivanti Connect Secure vulnerabilities to its Known Exploited Vulnerabilities Catalog on October 30, CVE-2026-111357 and CVE-2026-118527, both on evidence of active exploitation.
Infrastructure
APPLIED BLOCKCHAIN INC 2.75% Notes due 2030, CUSIP 038169AB4, printed at 194.6822 at 14:47:50 ET on 2026-10-30, down from a previous print of 212.978.
Infrastructure
APPLIED BLOCKCHAIN INC 2.75% Notes due 2030, CUSIP 038169AB4, printed at 194.6822 at 14:47:50 ET on 2026-10-30, down from a previous print of 212.978 and 203.46 points below its latest fund mark.
Politics
Secretary Scott Bessent announced new fraud prevention measures in Minnesota, including a FinCEN alert on cross-border payments through money services businesses and a notice on charities used for illicit activity.
Infrastructure
The UK government approved Sea Link on October 30, a 2 gigawatt undersea electricity connection between Suffolk and Kent developed by National Grid, capable of carrying power for the equivalent of 2 million homes.
Infrastructure
Global Payments shares jumped 12 percent on Friday after the Financial Times reported that Clayton, Dubilier & Rice is exploring a buyout of the payments processor at a reported enterprise value of $40 billion, teaming with GTCR, the company's largest outside shareholder.
Politics
Russian presidential aide Yuri Ushakov said Moscow and Washington have begun coordinating the exact date of a Russia, US and Ukraine trilateral meeting in Abu Dhabi, and that it will definitely take place in November.
Life Sciences
The FDA has pushed the PDUFA goal date for Agios' mitapivat in sickle cell disease from November 1, 2026 to February 1, 2027, after classifying the company's response to a safety information request as a major amendment.